Summary by Moomoo AI
On November 25, 2024, Fosun Pharma repurchased 0.128 million shares of common stock on the Hong Kong Stock Exchange, with a buyback price ranging from HKD 14 to HKD 14.1, totaling approximately HKD 1.7958 million. The shares repurchased will be held as inventory, with no plans for cancellation. The buyback authorization was approved on June 26, 2024, for a total authorized repurchase of 55.194 million shares. After the buyback, the total issued shares of Fosun Pharma will be 0.546 billion shares, increasing the inventory shares to 0.593 million shares. According to regulations, no new shares can be issued or inventory shares sold within 30 days after the buyback, with the suspension period ending on December 25, 2024.
